205.55

0.50% 1.03

Astrazeneca Plc (AZN)

Überblick Nachrichten Preisverlauf Optionskette Warum fällt AZN? Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$204.52

Offen:

$205.64

24-Stunden-Volumen:

2.50M

Relative Volume:

0.41

Marktkapitalisierung:

$318.66B

Einnahmen:

$58.80B

Nettoeinkommen (Verlust:

$10.24B

KGV:

62.69

EPS:

3.2788

Netto-Cashflow:

$8.98B

1W Leistung:

+6.49%

1M Leistung:

+117.49%

6M Leistung:

+163.73%

1J Leistung:

+176.09%

1-Tages-Spanne:

$204.09

$206.71

1-Wochen-Bereich:

$187.06

$206.71

52-Wochen-Spanne:

$61.24

$206.71

Astrazeneca Plc Stock (AZN) Company Profile

Firmenname

Astrazeneca Plc

Sektor

Healthcare (1111)

Branche

Drug Manufacturers - General (20)

Telefon

Adresse

Mitarbeiter

94,300

Twitter

@AstraZeneca

Nächster Verdiensttermin

2026-02-10

Neueste SEC-Einreichungen

AZN's Discussions on Twitter

Compare AZN vs LLY, JNJ, ABBV, NVS

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
AZN Astrazeneca Plc	205.55	317.06B	58.80B	10.24B	8.98B	3.2788
LLY Lilly Eli Co	1,040.00	929.27B	65.18B	20.64B	6.44B	22.96
JNJ Johnson Johnson	243.45	589.19B	94.19B	26.80B	19.70B	11.05
ABBV Abbvie Inc	231.50	402.08B	61.16B	4.20B	19.68B	2.3671
NVS Novartis Ag Adr	163.10	307.56B	54.72B	14.02B	15.32B	7.1855

Astrazeneca Plc Stock (AZN) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-01-27	Eingeleitet	Citigroup	Buy
2025-10-27	Fortgesetzt	Jefferies	Buy
2025-10-16	Herabstufung	Deutsche Bank	Hold → Sell
2025-04-15	Eingeleitet	Exane BNP Paribas	Outperform
2025-02-13	Hochstufung	UBS	Neutral → Buy
2025-02-12	Eingeleitet	Morgan Stanley	Overweight
2024-11-20	Hochstufung	UBS	Sell → Neutral
2024-11-06	Hochstufung	Deutsche Bank	Sell → Hold
2024-09-13	Herabstufung	Deutsche Bank	Hold → Sell
2024-05-30	Eingeleitet	Goldman	Buy
2024-04-16	Hochstufung	Deutsche Bank	Sell → Hold
2024-02-08	Herabstufung	Deutsche Bank	Hold → Sell
2024-01-23	Eingeleitet	Morgan Stanley	Overweight
2024-01-16	Fortgesetzt	UBS	Sell
2024-01-03	Herabstufung	Jefferies	Buy → Hold
2023-12-18	Eingeleitet	HSBC Securities	Buy
2023-09-25	Hochstufung	Jefferies	Hold → Buy
2023-07-14	Eingeleitet	HSBC Securities	Buy
2023-07-12	Hochstufung	UBS	Neutral → Buy
2023-07-05	Herabstufung	Deutsche Bank	Buy → Hold
2023-04-11	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2023-01-05	Eingeleitet	BMO Capital Markets	Outperform
2022-09-15	Herabstufung	Credit Suisse	Outperform → Neutral
2022-09-07	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2022-08-29	Hochstufung	Argus	Hold → Buy
2022-06-14	Herabstufung	UBS	Buy → Neutral
2022-02-11	Hochstufung	DZ Bank	Sell → Hold
2021-12-07	Herabstufung	Jefferies	Buy → Hold
2021-08-12	Fortgesetzt	JP Morgan	Overweight
2021-04-12	Herabstufung	Argus	Buy → Hold
2021-03-16	Hochstufung	Jefferies	Hold → Buy
2021-02-25	Hochstufung	UBS	Neutral → Buy
2021-01-15	Eingeleitet	Deutsche Bank	Buy
2020-12-07	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2020-11-30	Hochstufung	UBS	Sell → Neutral
2020-11-11	Hochstufung	HSBC Securities	Reduce → Hold
2020-09-29	Eingeleitet	Berenberg	Buy
2019-11-22	Eingeleitet	SVB Leerink	Outperform
2019-10-25	Hochstufung	Liberum	Hold → Buy
2019-04-02	Herabstufung	UBS	Neutral → Sell
2019-02-05	Eingeleitet	Exane BNP Paribas	Outperform
2019-01-25	Hochstufung	Shore Capital	Hold → Buy
2018-12-11	Fortgesetzt	Jefferies	Hold
2018-10-09	Eingeleitet	Guggenheim	Buy
2018-08-16	Herabstufung	Jefferies	Buy → Hold
2018-03-19	Hochstufung	Jefferies	Hold → Buy
2018-02-06	Bestätigt	Leerink Partners	Mkt Perform
2018-02-05	Bestätigt	Bernstein	Outperform
2018-01-18	Bestätigt	Leerink Partners	Mkt Perform
2017-12-29	Hochstufung	JP Morgan	Neutral → Overweight
2017-10-16	Hochstufung	Credit Suisse	Neutral → Outperform
2017-09-25	Hochstufung	Exane BNP Paribas	Neutral → Outperform
2017-09-22	Hochstufung	Bernstein	Mkt Perform → Outperform

Alle ansehen

Astrazeneca Plc Aktie (AZN) Neueste Nachrichten

04:08 AM

Cookson Peirce & Co. Inc. Invests $1.05 Million in AstraZeneca PLC $AZN - MarketBeat

04:08 AM

03:07 AM

Advisors Asset Management Inc. Acquires 8,453 Shares of AstraZeneca PLC $AZN - MarketBeat

03:07 AM

Feb 13, 2026

Shore Capital downgrades AstraZeneca as R&D spending dampens earnings trajectory - Yahoo Finance

Feb 13, 2026

AstraZeneca's BREZTRI Shows Significant Asthma Improvement in Phase III Trials - Intellectia AI

Feb 13, 2026

Caprock Group LLC Takes $3.10 Million Position in AstraZeneca PLC $AZN - MarketBeat

Feb 13, 2026

AstraZeneca Announces BrePREMIUM Trial Results - Intellectia AI

Feb 13, 2026

AstraZeneca Says Breztri Improves Lung Function, Reduces Attacks in Phase 3 Asthma Trials - marketscreener.com

Feb 13, 2026

AstraZeneca Earnings: Strong Finish to Year, and Busy Schedule of Data Readouts Ahead - Morningstar Canada

Feb 13, 2026

AstraZeneca PLC (LON:AZN) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock? - Yahoo Finance

Feb 13, 2026

Feb 12, 2026

NIH Stops Johnson & Johnson's Blood Thinner Drug Arm In Stroke Trial After Safety Review (UPDATED) - Benzinga

Feb 12, 2026

AstraZeneca's Portfolio and Pipeline Support Solid Long-Term Growth - Morningstar

Feb 12, 2026

6,649 Shares in AstraZeneca PLC $AZN Acquired by Westover Capital Advisors LLC - MarketBeat

Feb 12, 2026

Here’s What Lifted AstraZeneca PLC (AZN) in Q4 - Insider Monkey

Feb 12, 2026

Madison Asset Management LLC Trims Stock Holdings in AstraZeneca PLC $AZN - MarketBeat

Feb 12, 2026

Big Deal, Bigger Doubts: CSPC Slides After $18.5B Pact With AstraZeneca - Benzinga

Feb 12, 2026

Kangtai Drops Plan for China Vaccine JV With AstraZeneca - Citeline News & Insights

Feb 12, 2026

Feb 11, 2026

AstraZeneca awards $3.4 million to US nonprofits to expand healthcare access - MSN

Feb 11, 2026